Metraipolis › archive › dc_2b4cd3ca165d

Clinically approved immunotoxins targeting hematological cancers: "the best of both worlds" — Europe PMC PMID:41181593

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41181593
DOI: 10.3389/fphar.2025.1569502
License (as archived): solo-consultazione
Archived: 2026-11-09T06:02:11.493Z
SHA-256 of the archived text: f5027a64dddcf8547ba0eeb6cd209a5a1d19284daadcb945beec5ea2d177cc2d
Stable URL of this page: https://metraipolis.com/documento/dc_2b4cd3ca165d

How to cite

Clinically approved immunotoxins targeting hematological cancers: "the best of both worlds" — Europe PMC PMID:41181593 — Europe PMC (en), https://europepmc.org/article/MED/41181593 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b4cd3ca165d (Metraipolis archive dc_2b4cd3ca165d, sha256 f5027a64dddcf8547ba0eeb6cd209a5a1d19284daadcb945beec5ea2d177cc2d)

BibTeX

@misc{dc2b4cd3ca165d,
  title = {Clinically approved immunotoxins targeting hematological cancers: "the best of both worlds" — Europe PMC PMID:41181593},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41181593},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b4cd3ca165d; sha256 f5027a64dddcf8547ba0eeb6cd209a5a1d19284daadcb945beec5ea2d177cc2d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41181593. Agents can read the archived copy with the MCP tool read_document.